Rubius Therapeutics Inc (OTC Pink - Limited Information:RUBY)
| 0.0204 Delayed Data As of May 26 |  +0.0031 / +17.92%Today’s Change | 0.01 Today|||52-Week Range 1.57 | -88.34% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Appelhans Dannielle Chief Operating Officer |  Sale | 8/10/2022 | 5,737 | $0.80 | $4.6K | -97.42% |
Cagnoni Pablo J Director | Sale | 2/01/2023 | 8,448 | $0.25 | $2.1K | -92.44% |
Cagnoni Pablo J Director | Sale | 1/31/2023 | 7,240 | $0.24 | $1.7K | -92.17% |
Appelhans Dannielle President & Chief Executive Officer | Sale | 2/24/2023 | 10,385 | $0.13 | $1.4K | -83.00% |
Appelhans Dannielle President & Chief Executive Officer | Sale | 2/01/2023 | 3,878 | $0.25 | $969.50 | -92.44% |
Turka Laurence Chief Scientific Officer | Sale | 1/31/2023 | 2,593 | $0.24 | $622.32 | -92.17% |
Turka Laurence Chief Scientific Officer |  Buy | 1/29/2023 | 7,438 | $0.00 | $0.00 | -91.97% |
Turka Laurence Chief Scientific Officer | Buy | 1/31/2023 | 8,625 | $0.00 | $0.00 | -92.17% |
Cagnoni Pablo J Director | Buy | 1/29/2023 | 21,250 | $0.00 | $0.00 | -91.97% |
Cagnoni Pablo J Director | Buy | 1/31/2023 | 25,000 | $0.00 | $0.00 | -92.17% |
Page of 2